AbbVie buys Allergan for $63 bln

Reuters - Business (Amazon FireTV)
06/25/2019 | 1 min | NOT-RATED
AbbVie, which produces the blockbuster drug Humira, is buying the maker of Botox, Allergan, for about $63 billion. As Fred Katayama reports, AbbVie was under pressure to diversify its lineup of drugs.